Circulating tumor DNA in breast cancer: updates from SABCS 2025
Abstract Circulating tumor DNA (ctDNA) has emerged as a transformative biomarker in breast cancer, enabling sensitive assessment of tumor burden, molecular residual disease, and treatment resistance. Data presented at the 2025 San Antonio Breast Cancer Symposium (SABCS) demonstrate that ctDNA has mo...
Na minha lista:
| Principais autores: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2026-05-01
|
| coleção: | Journal of Hematology & Oncology |
| Acesso em linha: | https://doi.org/10.1186/s13045-026-01808-4 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|